Yaws

Yaws
Public domain · source
Name	Yaws
Caption	Cutaneous lesion associated with tropical infection
Field	Dermatology, Infectious disease
Symptoms	Ulcerative skin lesions, bone deformities
Complications	Gummatous destruction, chronic disability
Onset	Childhood
Causes	Bacterium
Diagnosis	Clinical, serology, PCR
Differential	Leprosy, Buruli ulcer, cutaneous tuberculosis
Prevention	Mass treatment campaigns, improved hygiene
Medication	Azithromycin, benzathine penicillin

Yaws is a chronic infectious disease primarily affecting skin, bones, and cartilage in children living in tropical regions. It is caused by a spirochetal bacterium and transmitted by direct nonsexual skin contact, leading to characteristic papillomatous and destructive lesions if untreated. Global eradication campaigns have been undertaken by agencies and nations, with recent renewed interest due to simplified antibiotic regimens and molecular diagnostic advances.

Introduction

Yaws is an endemic treponemal disease with focal prevalence in parts of Africa, Southeast Asia, the Pacific, and Latin America. Public health organizations such as the World Health Organization, national ministries of health, and nongovernmental organizations have mounted mass-treatment efforts analogous to those used against smallpox and guinea worm disease. Clinical management has involved collaboration among institutions like the Centers for Disease Control and Prevention, research consortia in universities, and pharmaceutical manufacturers producing antibiotics. Historical eradication initiatives in the mid-20th century reduced prevalence dramatically, prompting recent surveillance and research by groups linked to London School of Hygiene & Tropical Medicine, Pasteur Institute, and regional health programs.

Signs and symptoms

Primary lesions typically appear as papillomas or ulcers on exposed skin and mucosa in children, often on lower limbs and face. These lesions are painless or mildly painful and may be mistaken for lesions described in case reports from physicians at hospitals such as Mayo Clinic, Johns Hopkins Hospital, and university dermatology departments. Secondary lesions can manifest as widespread papillomatous eruptions, bone periostitis, and joint swelling—features seen in clinical reviews originating from hospitals affiliated with University of Oxford, Harvard Medical School, and other academic centers. Tertiary yaws may present years after infection with destructive gummatous lesions of skin and bone, leading to deformities historically documented in archives of missions and colonial era hospitals in regions administered by entities like the British Empire, French Colonial Empire, and Kingdom of Spain.

Cause and pathophysiology

The causative agent is a subspecies of treponemal spirochete closely related to the agent of venereal treponematoses identified in microbiology studies at institutions including the Pasteur Institute and University of Pennsylvania. Transmission occurs via skin-to-skin contact, often during play among children in rural communities, a pattern noted in field studies conducted by researchers from University of California, San Francisco, University of Sydney, and regional health services. The bacterium invades the dermis and can disseminate to periosteum and cartilage, eliciting inflammation and granulomatous responses described in pathology texts from Massachusetts General Hospital and comparative immunology studies at Stanford University.

Diagnosis

Diagnosis is primarily clinical in endemic areas, supported by serological tests such as treponemal and non-treponemal assays developed and standardized by laboratories including Centers for Disease Control and Prevention and commercial manufacturers. Polymerase chain reaction assays permit molecular confirmation in specimens, techniques refined in molecular labs at University of Cambridge and Karolinska Institutet. Differential diagnosis requires exclusion of conditions treated in tropical medicine clinics like leprosy (managed historically at specialized leprosaria), Buruli ulcer (investigated by World Health Organization collaborations), and cutaneous tuberculosis cases referenced in case series from University of Cape Town.

Treatment and prevention

Single-dose oral azithromycin has superseded intramuscular benzathine penicillin in many mass-treatment strategies following randomized trials coordinated by centers including London School of Hygiene & Tropical Medicine and World Health Organization. Mass drug administration campaigns—modeled on eradication frameworks used against smallpox and polio by agencies such as UNICEF—aim to treat whole communities and interrupt transmission. Preventive measures emphasize community hygiene, active case finding by public health teams from ministries and partners such as Doctors Without Borders, and surveillance integrated into routine programs run by regional health authorities. Vaccine development has been limited, with research programs at academic institutes exploring treponemal antigens analogous to vaccine research efforts at National Institutes of Health.

Epidemiology

Yaws historically affected millions across tropical belt territories administered by colonial powers and recorded in demographic studies by colonial health services. Mid-20th century eradication campaigns led by World Health Organization and UNICEF drastically reduced prevalence, but focal resurgence persists in parts of Papua New Guinea, Ghana, Solomon Islands, Vanuatu, and regions of Southeast Asia. Surveillance data are compiled by national public health institutes and international partners like WHO Regional Office for Africa and Pacific Community. Epidemiological patterns show highest incidence among children aged 2–15, with transmission linked to overcrowded living conditions and limited access to health services analyzed in population health studies by institutions such as London School of Hygiene & Tropical Medicine.

History and research

Descriptions of yaws-like lesions appear in accounts by explorers and colonial physicians in archives including correspondences preserved in Royal Geographical Society and medical mission reports. The bacteriological discovery of treponemes was advanced by researchers at the Pasteur Institute and laboratories in Germany and France during the late 19th and early 20th centuries. Large-scale eradication efforts in the 1950s–1960s, coordinated by WHO and UNICEF, demonstrated feasibility but did not achieve global eradication. Contemporary research focuses on molecular epidemiology, drug resistance surveillance by networks including Global Health Network, and implementation science to adapt mass-treatment strategies used successfully by campaigns against yaws-like neglected tropical diseases. Recent randomized controlled trials and field studies published by collaborations among universities and public health agencies continue to shape policy and operational guidelines.

Category:Tropical diseases